Rankings for Scientist

University, Subject, Country, Region, World

Johnson & Johnson Co. Scientists Rankings 2024

map
×
Total 420 scientist, 1 country, 1 university
AD Scientific Index - World Scientists Rankings - 2024 H INDEX i10 INDEX CITATION
University / Institution Country Region World Name Country University / Institution Subject Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total
1 1,353 1,449 2,879
Jesse A BerlinJesse A Berlin i
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Epidemiology and Public Health

Meta-analysis | epidemiology |

127 68 0.535 313 208 0.665 183,444 87,359 0.476
2 1,433 1,535 3,054
Manji HManji H
United States Johnson & Johnson Co. Johnson & Johnson Co.

126 57 0.452 288 190 0.660 52,891 12,907 0.244
3 4,053 4,403 8,662
Guang Chen (陈光）Guang Chen (陈光）
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Psychiatry

Neuropsychopharmacology | Neuroscience | Psychiatry | Translational Medicine |

96 71 0.740 559 470 0.841 52,996 37,272 0.703
4 6,462 7,044 13,960
Dirk GeversDirk Gevers
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Human Microbiome Institute

84 69 0.821 110 104 0.945 75,341 50,240 0.667
5 6,668 7,275 14,476
Matthew BreyerMatthew Breyer
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen pharmaceutical

medicine | kidney |

84 36 0.429 195 115 0.590 23,395 4,790 0.205
6 7,675 8,364 16,776
Jeffrey R InfanteJeffrey R Infante
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen, Research & Development, LLC

Oncology Early Drug Development |

80 64 0.800 312 203 0.651 33,978 20,063 0.590
7 11,906 13,097 27,135
Daniel J CuaDaniel J Cua
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Immunology

Immunology Discovery | Immuno-oncology Discovery |

69 49 0.710 122 97 0.795 58,551 18,095 0.309
8 12,515 13,793 28,647
Amy J JohnsonAmy J Johnson
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Research and Development

68 45 0.662 153 110 0.719 24,588 12,134 0.493
9 14,854 16,434 34,804
Iqbal S GrewalIqbal S Grewal
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Immunology

Immunology | Oncology | Autoimmunity | Cancer Immunology | Costimulation |

64 28 0.438 108 67 0.620 16,096 2,530 0.157
10 18,145 20,150 43,507
Hartmuth C KolbHartmuth C Kolb
United States Johnson & Johnson Co. Johnson & Johnson Co. Johnson & Johnson Janssen R&D

Molecular Imaging | Alzheimer's Disease imaging | neuroscience biomarkers | click chemistry |

59 36 0.610 146 97 0.664 42,132 13,127 0.312

The most comprehensive analysis and comparisons about your institution
11 23,761 26,485 58,996
Raymond EversRaymond Evers
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Pharmaceuticals

Drug transporters | Drug-Drug Interactions | Enzyme Induction | Drug-Induced Liver Injury | ADME |

53 29 0.547 87 62 0.713 16,039 4,474 0.279
12 24,602 27,470 61,687
Rob VreekenRob Vreeken
United States Johnson & Johnson Co. Johnson & Johnson Co. Associate Professor at M4I & Head Discovery & Exploratory BioAnalysis at Janssen R&D

53 37 0.698 102 83 0.814 7,374 3,764 0.510
13 24,630 27,502 61,754
Barbara WeirBarbara Weir
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Molecular Biology & Genetics

Cancer genomics | Computational Biology | Functional genetic screens |

52 40 0.769 63 57 0.905 44,435 22,973 0.517
14 25,725 28,749 65,128
Kiran PatelKiran Patel
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Medical Oncology

oncology |

51 40 0.784 118 89 0.754 27,262 18,692 0.686
15 27,443 30,733 69,930
Lloyd S MillerLloyd S Miller
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Immunology

Immunology |

50 44 0.880 108 99 0.917 10,295 5,978 0.581
16 28,764 32,239 73,857
Frederic BaribaudFrederic Baribaud
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen R&D

Digital Health | Drug Development | Immune-Mediated Diseases |

49 31 0.633 70 58 0.829 9,494 3,531 0.372
17 30,548 34,281 79,588
David P BrooksDavid P Brooks
United States Johnson & Johnson Co. Johnson & Johnson Co. Director, Business Development

Hypertension |

48 13 0.271 145 20 0.138 7,051 929 0.132
18 31,521 35,392 82,516
Noel A BrennanNoel A Brennan
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Ophthalmology

Vision | Optics | Myopia | Ophthalmology | Contact Lenses Eye Cornea Optometry Oxygen Physiology Comfort |

47 27 0.574 126 65 0.516 8,380 3,247 0.387
19 33,149 37,256 87,760
Rodney MasonRodney Mason
United States Johnson & Johnson Co. Johnson & Johnson Co. Ethicon Inc

46 23 0.500 83 43 0.518 7,314 1,616 0.221
20 35,664 40,088 95,489
Avijit GhoshAvijit Ghosh
United States Johnson & Johnson Co. Johnson & Johnson Co. Johnson and Johnson

Computational Chemistry | Computational Biology | Systems Biology | Pharmacokinetics | Pharmacodynamics |

44 31 0.705 195 130 0.667 9,112 5,691 0.625
21 35,735 40,169 95,694
Ziad S SaadZiad S Saad
United States Johnson & Johnson Co. Johnson & Johnson Co. Johnson & Johnson

44 36 0.818 62 58 0.935 8,753 4,670 0.534
22 35,989 40,460 96,445
Johannes LangedijkJohannes Langedijk
United States Johnson & Johnson Co. Johnson & Johnson Co.

44 23 0.523 94 51 0.543 7,799 3,695 0.474
23 36,016 40,488 96,521
Herman Van VlijmenHerman Van Vlijmen
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Chemical Sciences

Computational Biology | Computational Chemistry | Structural Biology |

44 29 0.659 88 63 0.716 7,719 3,436 0.445
24 36,177 40,676 97,040
MH BlackMH Black
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Molecular Biology & Genetics

statistical genetics | genomics | genetic epidemiology |

44 33 0.750 71 65 0.915 7,247 5,129 0.708
25 36,701 41,290 99,122
Anindya BhattacharyaAnindya Bhattacharya
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen, Johnson & Johnson, Roche, Buffalo

44 35 0.795 93 72 0.774 5,485 3,611 0.658
26 38,268 43,101 104,051
Whim (Pim) Drinkenburg|Wilhelmus H.I.M.Whim (Pim) Drinkenburg|Wilhelmus H.I.M.
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Neuroscience

Neuroscience |

43 29 0.674 98 70 0.714 5,801 2,755 0.475
27 39,145 44,078 106,596
M Soledad CepedaM Soledad Cepeda
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Research & Development

42 30 0.714 86 59 0.686 8,128 3,012 0.371
28 39,991 45,031 109,491
Xavier LangloisXavier Langlois
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Neuroscience

Neuroscience |

42 22 0.524 84 50 0.595 5,778 1,640 0.284
29 40,339 45,433 110,876
Mark CurranMark Curran
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Immunology

Immunology | neuroscience | diagnostics | personalized medicine |

41 26 0.634 57 37 0.649 16,759 3,038 0.181
30 40,420 45,520 111,046
Mathai MammenMathai Mammen
United States Johnson & Johnson Co. Johnson & Johnson Co. J&J

Research and Development |

41 16 0.390 103 31 0.301 13,127 2,497 0.190
31 40,692 45,811 111,711
Jeffrey NyeJeffrey Nye
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Neuroscience

Neuroscience | Therapeutics development | Fostering Innovation |

41 21 0.512 62 32 0.516 9,251 1,672 0.181
32 41,587 46,831 114,539
Mehdi PiroozniaMehdi Pirooznia
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Molecular Biology & Genetics

Computational Genomics | Bioinformatics |

41 34 0.829 89 82 0.921 6,093 4,277 0.702
33 42,220 47,572 117,071
Srihari GopalSrihari Gopal i
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Research & Development

Schizophrenia | Neuroscience | Cardiovascular Disease | Pulmonary Disease | Rare Diseases |

40 33 0.825 80 68 0.850 19,248 14,056 0.730
34 43,060 48,521 119,267
Pablo Garcia KilroyPablo Garcia Kilroy
United States Johnson & Johnson Co. Johnson & Johnson Co.

40 32 0.800 77 65 0.844 6,985 5,458 0.781
35 43,379 48,902 120,505
Honghui ZhouHonghui Zhou
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

pharmacokinetics/pharmacodynamics | drug-drug interaction | MIDD | QSP | clinical pharmacology |

40 27 0.675 102 72 0.706 6,082 2,700 0.444
36 45,586 51,423 127,890
Pamela J HornbyPamela J Hornby
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen, Johnson& Johnson

gastrointestinal pharmacology and metabolism |

39 22 0.564 95 39 0.411 5,524 1,641 0.297
37 46,474 52,426 131,224
William J MartinWilliam J Martin
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Neuroscience

Neuroscience |

38 20 0.526 75 41 0.547 11,036 2,599 0.236
38 47,207 53,241 133,226
Georgios StamatasGeorgios Stamatas
United States Johnson & Johnson Co. Johnson & Johnson Co. Johnson & Johnson Santé Beauté France

38 27 0.711 63 50 0.794 6,452 2,727 0.423
39 48,985 55,256 139,594
Amarnath SharmaAmarnath Sharma
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Clinical Pharmacology | Pharmaceutics | Drug Development |

37 19 0.514 65 40 0.615 7,932 1,938 0.244
40 50,761 57,313 146,177
Gary TresadernGary Tresadern
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Chemical Sciences

computational chemistry | molecular modelling | medicinal chemistry |

37 26 0.703 79 61 0.772 3,858 2,385 0.618

 New. 2023 Country Top Lists: Top 10000, 5000, 3000, 2000, 1000. Only in AD Scientific Index
41 50,917 57,481 146,762
Qingqin S LiQingqin S Li i
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Neuroscience

36 32 0.889 62 55 0.887 18,424 13,676 0.742
42 51,269 57,870 147,478
Dermot F ReillyDermot F Reilly
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Molecular Biology & Genetics

Genetics | Cardiometabolic | Retinal Disease |

36 32 0.889 48 44 0.917 8,677 6,447 0.743
43 51,926 58,603 149,343
David PolidoriDavid Polidori
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Research & Development, LLC

Drug Development | Mathematical Modeling | Pharmacology | Metabolic Diseases |

36 29 0.806 61 44 0.721 5,921 3,119 0.527
44 52,983 59,824 153,528
Dawn F IonescuDawn F Ionescu
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Psychiatry

Psychiatry | Anxious Depression | Treatment-Resistant Depression | Ketamine |

36 30 0.833 55 53 0.964 4,232 3,309 0.782
45 54,946 62,042 160,083
Ulf H BeierUlf H Beier
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen R&D

35 30 0.857 51 40 0.784 4,785 3,183 0.665
46 55,484 62,663 162,214
David C EvansDavid C Evans
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen

bioactivation | PBPK |

35 17 0.486 45 28 0.622 4,144 924 0.223
47 57,416 64,846 168,589
Juan Jose Perez RuixoJuan Jose Perez Ruixo
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Clinical Pharmacology | Pharmacometrics | Drug Development |

34 19 0.559 80 44 0.550 4,962 1,715 0.346
48 59,311 67,015 175,727
Anil KoulAnil Koul
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Biological Science

biological sciences | tuberculosis and kinases |

33 26 0.788 45 39 0.867 8,092 3,436 0.425
49 59,612 67,349 176,507
Brendan HodkinsonBrendan Hodkinson
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Molecular Biology & Genetics

Computational Biology | Bioinformatics |

33 26 0.788 49 40 0.816 6,339 4,002 0.631
50 60,063 67,866 177,890
Ian R HarrisIan R Harris
United States Johnson & Johnson Co. Johnson & Johnson Co. Johnson & Johnson

Regenerative therapy | wound healing | lipid metabolism | retina | cell therapy |

33 23 0.697 44 33 0.750 5,150 1,323 0.257
51 60,227 68,046 178,391
Filip CuyckensFilip Cuyckens
United States Johnson & Johnson Co. Johnson & Johnson Co. Head Analytical Sciences DMPK, Janssen R&D

mass spectrometry | drug metabolism | bioanalysis | 2D-LC | LC-MS |

33 23 0.697 69 49 0.710 4,897 2,031 0.415
52 60,339 68,172 178,780
Pejman SorooshPejman Soroosh
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Immunology

Immunology | Autoimmunity | metabolic disorders | asthma and allergy | infectious diseases |

33 29 0.879 39 38 0.974 4,727 2,859 0.605
53 61,212 69,199 182,177
İtalo Poggesiİtalo Poggesi
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

clinical pharmacology |

33 17 0.515 71 31 0.437 3,795 1,317 0.347
54 62,614 70,766 187,220
Gunaretnam RajagopalGunaretnam Rajagopal
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen R&D

Drug Discovery |

32 17 0.531 48 26 0.542 6,206 1,712 0.276
55 63,199 71,410 188,938
Tamas OraveczTamas Oravecz
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Johnson & Johnson

32 21 0.656 47 27 0.574 4,840 1,230 0.254

January 1, 2022 Total 716.979 scientist, 212 country, 14.130 university... January 6, 2023 Total 1.264.669 scientist, 216 country, 19.528 university
56 64,213 72,578 192,542
Michael SouthallMichael Southall
United States Johnson & Johnson Co. Johnson & Johnson Co. Research Director, Fellow. Johnson and Johnson

Skin Biology | Pharmacology | Natural Products Chemistry |

32 21 0.656 61 40 0.656 3,768 1,524 0.404
57 64,693 73,143 194,926
Guang-Ming DaiGuang-Ming Dai
United States Johnson & Johnson Co. Johnson & Johnson Co. Johnson and Johnson Vision

Vision | Aberration Theory | Optics | Astronomy | Algorithm |

32 19 0.594 67 47 0.701 3,299 1,335 0.405
58 66,582 75,256 200,876
Weirong WangWeirong Wang
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen R&D

drug development | PK/PD model | QSP | clinical pharmacology | therapeutic biologics |

31 24 0.774 40 32 0.800 4,503 1,750 0.389
59 67,850 76,679 205,858
Heng-Keang LimHeng-Keang Lim
United States Johnson & Johnson Co. Johnson & Johnson Co. Scientific Director and Fellow, Janssen R & D

Elemental mass spectrometry | molecular mass spectrometry | metabolic bioactivation and reactive metabolites |

31 14 0.452 49 20 0.408 3,290 896 0.272
60 70,068 79,197 213,713
Katrin SzardeningsKatrin Szardenings
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen

30 18 0.600 40 28 0.700 4,155 1,612 0.388
61 70,504 79,702 215,383
Jörg Kurt WegnerJörg Kurt Wegner
United States Johnson & Johnson Co. Johnson & Johnson Co. Principal Scientist and Team Leader AI Design Team, Janssen Pharmaceutica NV

Drug Design | Systems Biology | Augmented Intelligence | Bioinformatics | Computational Chemistry |

30 21 0.700 43 31 0.721 3,692 2,096 0.568
62 70,702 79,934 216,221
Helena GeysHelena Geys
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Pharma R&D + Hasselt University

Data Science | Biostatistics |

30 16 0.533 53 25 0.472 3,527 958 0.272
63 72,299 81,798 223,367
John LeeJohn Lee
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Pharmaceuticals

CAR-T | Cell Therapy | Gene Editing |

29 15 0.517 37 19 0.514 9,502 2,328 0.245
64 75,503 85,416 235,014
Arjen ScholtenArjen Scholten
United States Johnson & Johnson Co. Johnson & Johnson Co. Principal Scientist Analytical Development; Janssen Vaccines & Prevention

Mass Spectrometry | Immuno-Proteomics | Vaccines | Adenoviruses |

29 19 0.655 43 30 0.698 2,564 1,130 0.441
65 76,481 86,512 238,455
Hinrich Wh GöhlmannHinrich Wh Göhlmann
United States Johnson & Johnson Co. Johnson & Johnson Co. Scientific Director at Johnson & Johnson

Biomarker Research | Drug Discovery | Single Cell Profiling | High Dimensional Biology Technologies | Computational Sciences |

28 16 0.571 44 23 0.523 5,815 2,097 0.361
66 77,650 87,809 242,027
Matthew D PutnamMatthew D Putnam
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical Director @ DePuy Synthes, J&J; COL(Ret) USAR: Prof. U of MN (Ret)

Medical Product Development | Surgical Skill Testing | Bio-mechanical Models | Medical database development |

28 17 0.607 42 25 0.595 3,598 1,489 0.414
67 77,798 87,983 242,637
Christopher B KellyChristopher B Kelly
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Research and Development

Process Chemistry & Drug Discovery | Oxoammonium Salts | Organofluorine Chemistry | Strained Rings | Photoredox Catalysis |

28 24 0.857 45 41 0.911 3,462 2,682 0.775
68 80,060 90,562 252,881
Xiang LiXiang Li
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Mathematical Sciences

Statistics | Computing | Clinical Trial | Epidemiology |

27 21 0.778 34 33 0.971 12,416 10,217 0.823
69 80,638 91,195 254,073
Bevan Emma HuangBevan Emma Huang
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

statistical genetics | precision medicine |

27 21 0.778 35 28 0.800 5,388 3,409 0.633
70 80,684 91,245 254,194
Stefan KostenseStefan Kostense
United States Johnson & Johnson Co. Johnson & Johnson Co.

27 15 0.556 32 16 0.500 5,224 926 0.177
71 81,974 92,666 257,909
Khaled SarsourKhaled Sarsour
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Research and Development of the Johnson and Johnson Comapnies

Healthcare Data Science | Drug Development | Real World Evidence | External Control Arms |

27 24 0.889 40 33 0.825 3,340 2,301 0.689
72 82,041 92,744 258,186
Justin ScheerJustin Scheer
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Gene Therapy and Gene Delivery | Drug Discovery | T-cell Engagers | Immuno-Oncology | Protein Engineering |

27 20 0.741 42 36 0.857 3,280 1,484 0.452
73 82,763 93,583 260,967
Tc SarichTc Sarich
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

cardiovascular | metabolic disease | RWE | digital health | thrombosis |

27 15 0.556 43 17 0.395 2,843 950 0.334
74 83,453 94,378 264,102
Leah E AluisioLeah E Aluisio
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Neuroscience

Neuroscience | Mood Disorders | Biomarkers |

27 17 0.630 31 25 0.806 2,507 1,053 0.420
75 83,767 94,741 265,687
Yue GuoYue Guo
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmaceutical Sciences |

27 26 0.963 36 36 1.000 2,346 1,810 0.772
76 84,081 95,103 267,506
Marc WisnudelMarc Wisnudel
United States Johnson & Johnson Co. Johnson & Johnson Co. Ethicon, Inc.

27 8 0.296 56 5 0.089 2,134 214 0.100
77 84,115 95,142 267,650
Richard Yc HuangRichard Yc Huang
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Chemical Sciences

Analytical Chemistry | Mass Spectrometry | HDX-MS | Protein footprinting | Biopysics |

27 23 0.852 46 40 0.870 2,114 1,620 0.766
78 84,276 95,332 268,556
Mahesh N SamtaniMahesh N Samtani
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Clinical Pharmacology & Pharmacometrics |

27 18 0.667 41 30 0.732 1,942 858 0.442
79 84,936 96,051 270,368
Le Bars M Or Gozariu M Or Strimbu M Or Gozariu-Strimbu MLe Bars M Or Gozariu M Or Strimbu M Or Gozariu-Strimbu M
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Immunology

immunology | rheumatology | gastroenterology | clinical research | pain |

26 21 0.808 45 29 0.644 5,536 1,773 0.320
80 85,542 96,723 271,969
Matteo CesaroniMatteo Cesaroni
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen R&D

Translation Informatics |

26 21 0.808 32 31 0.969 3,964 2,041 0.515
81 86,324 97,607 274,446
Lai-Ming YungLai-Ming Yung
United States Johnson & Johnson Co. Johnson & Johnson Co. Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson

cardiovascular biology | endothelial function | pulmonary vascular remodeling |

26 19 0.731 30 23 0.767 3,183 1,395 0.438
82 86,527 97,851 275,234
Willem TalloenWillem Talloen
United States Johnson & Johnson Co. Johnson & Johnson Co. Director, Janssen Pharmaceutcials group

Early development clinical trial design | Biomarkers | Statistical bio-informatics | omics data analysis |

26 17 0.654 46 26 0.565 3,034 1,327 0.437
83 87,174 98,601 277,840
Michael P MaherMichael P Maher
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Neuroscience

neuroscience | pharmacology | physics |

26 14 0.538 43 20 0.465 2,672 681 0.255
84 88,534 100,170 284,362
Shane KavanaghShane Kavanagh
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

health economics | epidemiology | real world evidence | outcomes research |

26 12 0.462 43 15 0.349 2,068 564 0.273
85 88,701 100,360 285,286
Nikolay V Manyakov|Маньяков Николай ВладимировичNikolay V Manyakov|Маньяков Николай Владимирович
United States Johnson & Johnson Co. Johnson & Johnson Co. Director Data Science, Johnson & Johnson

26 22 0.846 48 34 0.708 1,971 1,326 0.673
86 89,963 101,752 289,365
Gopi ShankarGopi Shankar
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen R&D, LLC (Johnson & Johnson, Inc)

25 17 0.680 39 24 0.615 4,158 1,475 0.355
87 90,522 102,369 290,902
Chantal HolyChantal Holy
United States Johnson & Johnson Co. Johnson & Johnson Co.

25 19 0.760 45 36 0.800 3,422 1,222 0.357
88 90,600 102,457 291,124
Angel Romo-UribeAngel Romo-Uribe
United States Johnson & Johnson Co. Johnson & Johnson Co. Johnson & Johnson, Advanced Science & Technology

biopolymers shape memory polymers | polymer nanocomposites | hydrogels | epoxies acrylic coatings | thermotropic polymers |

25 18 0.720 64 37 0.578 3,354 1,312 0.391
89 90,710 102,582 291,444
Gayle WittenbergGayle Wittenberg
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Neuroscience

Precision Neuroscience | Data Science | Digital Health | Molecular Informatics | Neuroimaging |

25 22 0.880 30 26 0.867 3,259 1,979 0.607
90 91,200 103,140 293,033
Victor VillalobosVictor Villalobos
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen oncology

25 21 0.840 36 31 0.861 2,919 2,274 0.779

Institutional Subscription (Discount and Free Institutional Academic Performance Report)
91 92,976 105,176 300,682
Jonggu ParkJonggu Park
United States Johnson & Johnson Co. Johnson & Johnson Co. R&D, Johnson & Johnson

Polymers | Biomaterials | Medical devices |

25 13 0.520 36 17 0.472 2,134 791 0.371
92 93,812 106,148 305,347
Yuqing (Anne) YangYuqing (Anne) Yang
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Molecular Biology & Genetics

epigenetics | Nrf2 |

25 24 0.960 30 30 1.000 1,733 1,275 0.736
93 94,367 106,769 307,401
Madhusudhanan SukumarMadhusudhanan Sukumar
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Autologous CAR-T | iPSC CAR-T & CAR-NK | Tumor microenvironment | Cell-based Therapy | TIL & TCR Therapy |

24 23 0.958 26 25 0.962 6,058 4,820 0.796
94 94,507 106,927 307,737
Ivo CornelissenIvo Cornelissen
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Oncology |

24 16 0.667 26 22 0.846 5,202 1,841 0.354
95 94,982 107,447 308,916
Wim Van Der ElstWim Van Der Elst
United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

24 20 0.833 44 32 0.727 3,956 1,965 0.497
96 97,535 110,320 317,596
David M KernDavid M Kern
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen Research & Development

24 20 0.833 47 43 0.915 2,227 1,468 0.659
97 97,681 110,488 318,244
Michela CapelloMichela Capello
United States Johnson & Johnson Co. Johnson & Johnson Co. The Janssen Pharmaceutical Companies of Johnson & Johnson

Cancer Research |

24 22 0.917 33 30 0.909 2,176 1,534 0.705
98 97,799 110,633 318,783
Ghulam M MaharviGhulam M Maharvi
United States Johnson & Johnson Co. Johnson & Johnson Co. Natural Sciences / Chemical Sciences

Synthetic Organic Chemistry | Medicinal Chemistry | Polymer Chemistry | Natural Products Chemistry | API's |

24 14 0.583 37 20 0.541 2,137 660 0.309
99 97,962 110,828 319,543
Gerold BongersGerold Bongers
United States Johnson & Johnson Co. Johnson & Johnson Co. Janssen R&D

Autoimmunity | Immunology | Microbiome |

24 20 0.833 27 24 0.889 2,082 1,021 0.490
100 98,914 111,898 324,353
Tamás VighTamás Vigh
United States Johnson & Johnson Co. Johnson & Johnson Co. Senior Scientist, Janssen R&D

24 23 0.958 34 32 0.941 1,766 1,448 0.820